Name:
Streptococcus pyogenes Rosenbach 1884
DSM No.:
2072 dsm-2072 dsm2072 dsm 2072 Streptococcus pyogenes
Other collection no.
or WDCM no.:
ATCC 21060
Isolated from:
derived from Streptococcus pyogenes ATCC 21059 (DSM 2071)
Country:
country of origin unknown
Date of sampling:
before 23.02.1981
Nagoya Protocol Restrictions:
There are NO known Nagoya Protocol restrictions for this strain.
History:
<- ATCC <- S. Koshimura, Su (Streptococcus hemolyticus)
Summary and
additional information:
<- ATCC <- S. Koshimura, Su (Streptococcus hemolyticus). Derived from Streptococcus pyogenes ATCC 21059 (DSM 2071). Produces streptolysin S (1937). Anti-tumor agent (U.S. Pat. 3,477,914) (1938). (Medium 82, 37°C)
Risk group:
2 (Z) (classification according to German
TRBA)
Restrictions:
Act dealing with the prevention & control of infectious diseases in man (Infektionsschutzgesetz),
Category A1Animal pathogenic organism,
not exported outside Germany,
Category F
Supplied as:
| Delivery form | | Prices |
|
| Freeze Dried | | 100,- € |
| Active culture on request | | 240,- € |
| DNA | | 150,- € | |
| Price Category for this culture: 1 |
Freight and handling charges will be added.
See price list.Note: Freight charges for Risk Group 2 microorganisms will apply.
